Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaowei Qiu

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|March 18, 2025
Treatment of pro-B acute lymphoblastic leukemia and severe plaque psoriasis with anti-CD19 CAR T cells: a case reportAo Zhang, Guangji Zhang, Huihui Yang, et al.
BMC Cancer|November 29, 2017
Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cellsShaowei Qiu, Shuang Liu, Tengteng Yu, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2024
Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemiaHaotian Ma, Zhifeng Yan, Runxia Gu, et al.
JCI Insight|November 22, 2022
Low c-Kit expression identifies primitive, therapy-resistant CML stem cellsMansi Shah, Harish Kumar, Shaowei Qiu, et al.
Blood Cancer Journal|September 16, 2024
Multiomic analysis identifies a high-risk subgroup that predicts poor prognosis in t(8;21) acute myeloid leukemiaYu Liu, Wenbing Liu, Anli Lai, et al.
Free Radical Biology & Medicine|January 15, 2025
U2AF1 mutation causes an oxidative stress and DNA repair defect in hematopoietic and leukemic cellsYishuang Li, Xuanjia Dong, Haiyan Xing, et al.
International Journal of Laboratory Hematology|July 21, 2021
Evaluation of pretreatment telomere length as a prognostic marker in intermediate-risk acute myeloid leukemiaRunxia Gu, Jingjing Cao, Shuning Wei, et al.
Leukemia Research|June 27, 2013
Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocationShuning Wei, Siping Wang, Shaowei Qiu, et al.
Blood Advances|October 1, 2021
Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemiaLianzhong Zhao, Pengcheng Zhang, Phillip M Galbo, et al.
The Journal of Clinical Investigation|June 11, 2019
SIRT1 regulates metabolism and leukemogenic potential in CML stem cellsAjay Abraham, Shaowei Qiu, Balu K Chacko, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|March 18, 2025
Treatment of pro-B acute lymphoblastic leukemia and severe plaque psoriasis with anti-CD19 CAR T cells: a case reportAo Zhang, Guangji Zhang, Huihui Yang, et al.
BMC Cancer|November 29, 2017
Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cellsShaowei Qiu, Shuang Liu, Tengteng Yu, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2024
Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemiaHaotian Ma, Zhifeng Yan, Runxia Gu, et al.
JCI Insight|November 22, 2022
Low c-Kit expression identifies primitive, therapy-resistant CML stem cellsMansi Shah, Harish Kumar, Shaowei Qiu, et al.
Blood Cancer Journal|September 16, 2024
Multiomic analysis identifies a high-risk subgroup that predicts poor prognosis in t(8;21) acute myeloid leukemiaYu Liu, Wenbing Liu, Anli Lai, et al.
Free Radical Biology & Medicine|January 15, 2025
U2AF1 mutation causes an oxidative stress and DNA repair defect in hematopoietic and leukemic cellsYishuang Li, Xuanjia Dong, Haiyan Xing, et al.
International Journal of Laboratory Hematology|July 21, 2021
Evaluation of pretreatment telomere length as a prognostic marker in intermediate-risk acute myeloid leukemiaRunxia Gu, Jingjing Cao, Shuning Wei, et al.
Leukemia Research|June 27, 2013
Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocationShuning Wei, Siping Wang, Shaowei Qiu, et al.
Blood Advances|October 1, 2021
Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemiaLianzhong Zhao, Pengcheng Zhang, Phillip M Galbo, et al.
The Journal of Clinical Investigation|June 11, 2019
SIRT1 regulates metabolism and leukemogenic potential in CML stem cellsAjay Abraham, Shaowei Qiu, Balu K Chacko, et al.
Pageof 7